IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Myelodysplastic/Myeloproliferative Diseases
Fred Hutchinson Cancer Centermonoclonal_antibodyPhase 2Dormant
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
46 Active assets in the Myelodysplastic/Myeloproliferative Diseases cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE M.D. Anderson Cancer Center | Phase 3 | BBB |
Evomela M.D. Anderson Cancer Center | Phase 2/3 | BBB |
Busulphan Jacqueline Garcia, MD | Phase 2/3 | BBB |
CYCLOSPORIN A Memorial Sloan Kettering Cancer Center | Phase 3 | BBB |
Cytosin-Arabinosid Fred Hutchinson Cancer Center | Phase 3 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →